Inpatient care of community-acquired pneumonia: The effect of antimicrobial guidelines on clinical outcomes and drug costs in Canadian teaching hospitals

Canadian Respiratory Journal

Volumn 11, Issue 2, 2004, Pages 131-137

  Marras, Theodore K ^a,b   Jamieson, Linda ^a   Chan, Charles K ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Economics; Length of stay; Mortality; Outcomes; Pharmaceutical; Pneumonia; Practice guidelines

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN; LEVOFLOXACIN; MACROLIDE; QUINOLONE DERIVATIVE;

ADULT; AGED; ANAEROBIC BACTERIUM; ARTICLE; CANADA; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; DRUG COST; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; TEACHING HOSPITAL;

EID: 1942475175     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/970828     Document Type: Article

References (29)

1. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993;137:977-88.
2. Foy HM, Cooney MK, Allan I, Kenny GE. Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975. JAMA 1979;241:253-8.
3. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther 1998;20:820-37.
4. LaForce FM. Community-acquired lower respiratory tract: Prevention and cost-control strategies. Am J Med 1985;78:52-7.
5. Helwig D. Major cost reductions reported in Canadian pneumonia study. eCMAJ Today, February 9, 2000. http://collection.nlc-bnc.ca/100/201/300/cdn_medical_association/ cmaj/cmaj_today/2000/02_09.htm(Version current at February 27, 2004).
6. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
7. Chow CW, Lee-Pack LR, Senathiragah N, Rawji M, Chan M, Chan CK. Community acquired, nursing home acquired and hospital acquired pneumonia: A five year review of the clinical, bacteriological and radiological characteristics. Can J Infect Dis 1995;6:317-25.
8. Marras TK, Chan CK. Use of guidelines in treating community-acquired pneumonia. Chest 1998;113:1689-94.
9. Woodhead MA, MacFarlane JT. Comparative clinical laboratory features on Legionella with pneumococcal and Mycoplasma pneumonias. Br J Dis Chest 1987;81:133-9.
10. Farr BM, Kaiser DL, Harrison BD, Connolly CK. Prediction of microbial etiology at admission to hospital for pneumonia from the presenting clinical features. Thorax 1989;44:1031-5.
11. Chan CHS, Cohen M, Pang J. A prospective study of community-acquired pneumonia in Hong Kong. Chest 1992; 10 1:442-6.
12. MacFarlane JT, Miller AC, Roderick Smith WH, Morris AH, Rose DH. Comparative radiographic features of community-acquired Legionnaires' disease, pneumococcal pneumonia, Mycoplasma pneumonia, and psittacosis. Thorax 1984;39:28-33.
13. Tew J, Calenoff L, Berlin BS. Bacterial or nonbacterial pneumonia: Accuracy of radiographic diagnosis. Radiology 1977;124:607-12.
14. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. The British Thoracic Society. Br J Hosp Med 1993;49:346-50.
15. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000;31:383-421.
16. Bartlett JG, Dowell SF, Mandell LA, File TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000;31:347-82.
17. ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society. Eur Respir J 1998;11:986-91.
18. Niederman MS, Mandell LA, Anzueto A, et al. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-54.
19. Heffelfinger JD, Dowell SF, Jorgensen JH, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance. Arch Intern Med 2000;160:1399-408.
20. Gleason PP, Kapoor WN, Stone RA, et al. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. JAMA 1997;278:32-9.
21. Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999,;159:2562-72.
22. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MJ, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 2000;283:749-55.
23. Mandell LA, Niederman MS, The Canadian Community-Acquired Pneumonia Consensus Group. Antimicrobial treatment of community acquired pneumonia in adults: A conference report. Can J Infect Dis 1993;4:25-8.
24. Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: Guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis 1998;26:811-38.
25. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 1989;11:586-99.
26. Feagan BG, Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. CMAJ 2000;162:1415-20.
27. Mortensen EM, Coley CM, Singer DE, et al. Causes of death for patients with community-acquired pneumonia. Arch Intern Med 2002;162:1059-64.
28. Flanders WD, Tucker G, Krishnadasan A, Martin D, Honig E, McClellan WM. Validation of the pneumonia severity index: Importance of study-specific recalibration. J Gen Intern Med 1999;14:333-40.
29. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med 1999;130:515-24.